Pharmafile Logo
Pharmafocus logo
Advanced Search

Sosei Heptares Confirms Changes to its Board and Executive Management Team at Annual Shareholders’ Meeting

March 23, 2023
Business Services

Tokyo, Japan and Cambridge, UK, 23 March 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …

News
Press release

PureTech Health and Royalty Pharma enter KarXT royalty agreement up to $500m

March 23, 2023
Sales and Marketing

Royalty Pharma have acquired a $500m interest in PureTech’s royalty in Karuna Therapeutics’ KarXT, with $100m cash up front and …

News

Biogen shares FDA decisions on ALS drug

March 23, 2023
Research and Development

US-based Biogen has announced two decisions the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee made surrounding its ALS …

News

Incyte has announced FDA approval of Zynyz

March 23, 2023
Medical Communications

Incyte has today announced that the FDA gas approved Zynyz (retifanlimab-dlwr) for the treatment of adult patients with metastatic or …

News

India cancels manufacturing licence for Marion Biotech after cough syrup deaths

March 23, 2023
Medical Communications

Uttar Pradesh, a state in India, has cancelled the manufacturing licence of Marion Biotech after two cough syrups made at …

News

AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease

March 22, 2023
Business Services

VANCOUVER, British Columbia & LONDON, March 22, 2023 – AbCellera (Nasdaq: ABCL) and RQ Bio announced today that they have …

News
Press release

Hadassah Selects YonaLink’s EHR-to-EDC Clinical Trial Platform to Securely and Seamlessly Integrate Clinical Care and Research Data

March 22, 2023
Business Services

Boston, March 22, 2023 — YonaLink, a clinical trial software provider, today announced its EHR-to-EDC data integration platform has been …

News
Press release

Bio-Rad Launches PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers

March 22, 2023
Business Services

HERCULES, Calif. — March 15, 2023 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science …

News
Press release

InvoX Pharma’s F-star announces licence agreement with Takeda for second novel next-generation immuno-oncology bispecific antibody

March 22, 2023
Business Services

LONDON, United Kingdom, March, 22, 2023 (GLOBE NEWSWIRE): InvoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited …

News
Press release

Dewpoint Therapeutics partners with Novo Nordisk to explore the field of biomolecular condensates to treat insulin resistance and diabetes progression

March 22, 2023
Business Services

Boston, Massachusetts March 22, 2023 – Dewpoint Therapeutics today announced a research and development partnership with Novo Nordisk to identify …

News
Press release

ELLAB LAUNCHES NEW MONITORING SOLUTION FOR LIFE-SAVING PRODUCTS

March 22, 2023
Business Services

Ellab has launched a new continuous monitoring solution for the biotech and pharmaceutical sectors, which accurately monitors critical processes 24/7. …

News
Press release

CANARY WHARF ATTRACTS LIFE SCIENCES FOCUSED STARTUPS AND SCALEUPS TO ITS TECHNOLOGY COMMUNITY AT LEVEL39

March 22, 2023
Business Services

22 March 2023: The development of a major life science cluster at Canary Wharf continues to build momentum with a …

News
Press release

Sequana Medical announces additional patents for DSR® in China and the United States

March 22, 2023
Business Services

Ghent, Belgium – 22 March 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana

News
Press release

Roche and Eli Lilly collaborate on Alzheimer’s disease blood test

March 22, 2023
Medical Communications

Swiss biotech company Roche has announced a collaboration with US pharmaceutical company Eli Lilly to develop Roche’s Elecsys Amyloid Plasma …

News

Kite’s Yescarta CAR T-cell therapy shows statistically significant improvement in overall survival

March 22, 2023
Research and Development

Kite has announced the primary overall survival (OS) analysis results of a phase 3 study into Yescarta for the treatment …

News

Promising ovarian cancer drug enters phase 3 trial

March 22, 2023

A new drug to treat ovarian cancer is set to enter the phase 3 UP-NEXT trial imminently.  Upifitamab rilsodotin is …

News

Faron Pharmaceuticals announces positive FDA feedback for solid tumour therapy

March 22, 2023
Research and Development

Faron Pharmaceuticals, a clinical stage biopharmaceutical company, has revealed positive FDA feedback and recommendations for its monotherapy for solid tumour …

News

Vaccitech’s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile at Interim Analysis in Women with Low-Grade Human Papillomavirus (HPV)-related Cervical Lesions

March 21, 2023
Business Services

OXFORD, United Kingdom, March 20, 2023 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company focused on the …

News
Press release

BioNTech and OncoC4 to partner for development and commercialisation of novel checkpoint antibody

March 21, 2023
Sales and Marketing

BioNTech and OncoC4 have entered a strategic collaboration for the co-development and commercialisation of a novel checkpoint antibody for multiple …

News

First candidate from Nurix-Gilead Sciences collaboration exclusively licensed

March 21, 2023
Research and Development

US-based Gilead Sciences and Nurix have announced that Gilead has exercised its option to exclusively license Nurix’s investigational targeted protein …

News
The Gateway to Local Adoption Series

Latest content

Biogen’s high-dose Spinraza regimen receives European Commission approval for spinal muscular atrophy

January 19, 2026

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026